Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Rating) major shareholder Perceptive Advisors Llc acquired 22,500 shares of the business’s stock in a transaction that occurred on Friday, May 26th. The stock was acquired at an average cost of $5.27 per share, with a total value of $118,575.00. Following the completion of the acquisition, the insider now […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Rating) major shareholder Perceptive Advisors Llc bought 27,300 shares of the stock in a transaction on Monday, May 22nd. The stock was purchased at an average cost of $5.12 per share, with a total value of $139,776.00. Following the acquisition, the insider now owns 1,916,955 shares in the company, […]
Soleno Therapeutics (NASDAQ:SLNO – Get Rating) and Movano (NASDAQ:MOVE – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations. Profitability This table compares Soleno Therapeutics and Movano’s net margins, […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Rating) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 108,200 shares, a growth of 27.6% from the March 31st total of 84,800 shares. Currently, 1.9% of the shares of the company are short […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Rating)’s stock price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $2.45 and traded as high as $3.95. Soleno Therapeutics shares last traded at $3.70, with a volume of 31,804 shares changing hands. Analyst Ratings Changes Separately, Oppenheimer […]